JNJ – johnson & johnson (US:NASDAQ)
Stock Stats
News
5/3
05:52 pm
jnj
Low
Celonis Appoints Mark Jacobs as Go-to-Market Leader for North America [Yahoo! Finance]
5/3
12:53 pm
jnj
Low
Phase 2 data for ERLEADA® ?(apalutamide) plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localised prostate cancer shows 100 percent biochemical free recurrence rate more than two years post-surgery [Yahoo! Fin
5/3
12:24 pm
jnj
Low
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localized prostate cancer show 100% biochemical free recurrence rate more than two years post-surgery [Yahoo! Finance]
5/3
12:05 pm
jnj
Low
TAR-200 monotherapy shows greater than 80 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer [Yahoo! Finance]
5/3
11:23 am
jnj
Low
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer [Yahoo! Finance]
4/16/2024
06:20 am
JNJ
-0.4%
BEAT
1/23/2024
06:20 am
JNJ
-1.8%
BEAT
10/17/2023
06:20 am
JNJ
-1.2%
BEAT
7/20/2023
06:20 am
JNJ
5.2%
BEAT
4/18
11:34 am
Upgrades
Hold
Buy
HSBC
Low
0.8%
4/18
11:34 am
Upgrades
Hold
Buy
HSBC
Low
0.8%
4/18
09:24 am
Upgrades
Hold
Buy
HSBC Holdings plc
Low
-0.2%
4/17
01:10 pm
Maintains
Outperform
Outperform
RBC Capital
Low
0.5%
4/17
01:10 pm
Maintains
Outperform
Outperform
RBC Capital
Low
0.5%
5/3
04:32 pm
jnj
Low
Form 4 JOHNSON & JOHNSON For: May 01 Filed by: REED JOHN C
5/1
07:10 am
jnj
Low
Form 10-Q JOHNSON & JOHNSON For: Mar 31
5/1
07:01 am
jnj
Low
Form 8-K JOHNSON & JOHNSON For: May 01
4/29
05:07 pm
jnj
Low
Form 4 JOHNSON & JOHNSON For: Apr 25 Filed by: Adamczyk Darius
4/29
05:07 pm
jnj
Low
Form 4 JOHNSON & JOHNSON For: Apr 25 Filed by: West Nadja
Show more
Top News Gainers
3/27 Form DEFA14A JOHNSON & JOHNSON 8.1%
3/12 Paul Harris' Top Picks: March 12, 2020 [Business News Network (BNN) Energy & Resources (Canada)] 7.5%
4/7 Is JNJ Stock A Buy On CEO's Bullish Call For Coronavirus Vaccine? [Investor's Business Daily] 4.6%
4/5 Will These 3 Coronavirus Stocks Lead the Market to Recovery? [Yahoo! Finance News] 4.3%
4/13 Stocks slip as market enters new phase, with investors worrying about balance sheets [CNBC] 4.0%
3/2 AODocs Joins AIIM Leadership Council, Showcases Innovative Approach to Information Management at 2020 AIIM Conference 3.9%
3/4 Johnson & Johnson ordered to pay $1.7 million to three Australian women in pelvic mesh class action [Reuters] 3.8%
3/18 Is This 1 Healthcare Stock Coronavirus-Proof? [The Motley Fool] 3.8%
3/24 What Technology And Manufacturing Can Do To Help Against COVID-19 [Forbes] 3.6%
4/1 5 of the Best Stocks to Buy for April [Yahoo! Finance News] 3.3%
Top News Decliners
3/21 Johnson and Johnson: A Safe Haven in Recession [The Motley Fool] -7.3%
3/20 Is Johnson & Johnson (NYSE:JNJ) Trading At A 35% Discount? [Yahoo! Finance News] -6.9%
3/10 J&J MET antibody nabs accelerated review status for certain lung cancer patients [Seeking Alpha] -6.8%
3/18 J&J files U.S. application for MS med ponesimod [Seeking Alpha] -6.6%
10/18 Wolves In Sheep’s Clothing: We Can’t Trust Businesses To Do Right By Americans Now [Forbes] -6.4%
5/28 Oklahoma taking on Johnson & Johnson in historic trial [MSNBC.com] -6.1%
3/13 Americans rush to stock up on essentials as coronavirus spreads [Reuters] -5.5%
3/11 Desperate to exit, a $10B price tag for Magic Leap is crazy [TechCrunch Blog] -4.9%
7/12 Johnson & Johnson (NYSE: JNJ) is now covered by analysts at Credit Suisse Group AG. They set an "outperform" rating and a $156.00 price target on the stock. -4.5%
3/6 Eyecare industry leaders sign Proclamation to focus on key issues facing the future of optometry -3.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3